Eurasian Hematology-Oncology Group

http://www.ehog.net/

 

Myeloma
18:43

7th Eurasian Hematology Oncology Summit

2020 Updates on CAR-T in R/R MM: What Is the Incidence of AEs With bb2121? Does Idecabtagene Vicleucel Improve ORR? Is Orvacabtagene Autoleucel Safe and Tolerable?

FEATURING Evangelos Terpos
  • 113 views
  • December 11, 2020
  • 1
14:20

7th Eurasian Hematology Oncology Summit

How I Treat Newly Diagnosed MM in 2020: Is VTD Superior to VCD? Is D-VTd Beneficial for PFS/OS in Transplant-Eligible Disease? Should We Use Thalidomide Maintenance After ASCT?

FEATURING Angelo Maiolino
  • 141 views
  • December 9, 2020
16:17

7th Eurasian Hematology Oncology Summit

VRd, KRd and IRd in R/R MM: Real World vs. Clinical Trial Data

FEATURING Ajai Chari
  • 482 views
  • December 9, 2020
  • 3
15:49

7th Eurasian Hematology Oncology Summit

2020 Updates on Maintenance Therapies in MM: Should We Consider Double Planned ASCT? Can Thalidomide Prolong PFS/OS? Is Ixazomib Beneficial in Newly Diagnosed Disease?

FEATURING Maria Gavriatopoulou
  • 79 views
  • December 9, 2020